Literature DB >> 2793162

The pathology of fungal infection and colonization in patients with cystic fibrosis.

V Bhargava1, J F Tomashefski, R C Stern, C R Abramowsky.   

Abstract

We used methenamine silver stains to retrospectively evaluate the prevalence of fungi and their associated inflammatory reactions in 63 patients with cystic fibrosis (CF) autopsied between 1982 and 1987. Fungi were detected in 13 patients (21%) who fell into three groups: respiratory tract colonization (five patients); localized infection (five patients); and disseminated infection (three patients). Hyphae consistent with Aspergillus sp were present in five patients; yeast-like cells and/or pseudohyphae consistent with Candida sp occurred in eight patients; and Histoplasma capsulatum produced fibrocaseous lymph node and splenic granulomas in one patient. Acute inflammation typified most fungal lesions, while bronchocentric granulomatosis affected one patient. Compared with patients with no fungi, those with fungi were more frequently treated with indwelling central venous catheters (P less than .05). Autopsy reports on 156 CF patients from 1964 to 1982 disclosed only one with disseminated mycosis (P less than .05). We conclude that stainable fungi can be found in CF patients at autopsy more frequently than previously realized. Fungi usually represent respiratory tract colonization or minimal localized infection, but the prevalence of fatal disseminated infection (4.8%) has also increased. Fungal infection in CF appears to be most closely associated with aggressive therapeutic intervention.

Entities:  

Mesh:

Year:  1989        PMID: 2793162     DOI: 10.1016/0046-8177(89)90269-4

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  8 in total

Review 1.  Commentary: unusual manifestations of aspergillosis.

Authors:  D W Denning
Journal:  Thorax       Date:  1995-07       Impact factor: 9.139

2.  A 33 kDa serine proteinase from Scedosporium apiospermum.

Authors:  G Larcher; B Cimon; F Symoens; G Tronchin; D Chabasse; J P Bouchara
Journal:  Biochem J       Date:  1996-04-01       Impact factor: 3.857

3.  Three cases of pulmonary aspergilloma in adult patients with cystic fibrosis.

Authors:  C P Maguire; J P Hayes; M Hayes; J Masterson; M X FitzGerald
Journal:  Thorax       Date:  1995-07       Impact factor: 9.139

4.  Exophiala dermatitidis pneumonia in cystic fibrosis.

Authors:  G Kusenbach; H Skopnik; G Haase; F Friedrichs; H Döhmen
Journal:  Eur J Pediatr       Date:  1992-05       Impact factor: 3.183

5.  Totally implantable venous access devices in children with cystic fibrosis: incidence and type of complications.

Authors:  J Deerojanawong; S M Sawyer; A M Fink; K B Stokes; C F Robertson
Journal:  Thorax       Date:  1998-04       Impact factor: 9.139

Review 6.  Lung infections associated with cystic fibrosis.

Authors:  Jeffrey B Lyczak; Carolyn L Cannon; Gerald B Pier
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

Review 7.  Aspergillus fumigatus in the cystic fibrosis lung: pros and cons of azole therapy.

Authors:  Pierre-Régis Burgel; André Paugam; Dominique Hubert; Clémence Martin
Journal:  Infect Drug Resist       Date:  2016-09-20       Impact factor: 4.003

8.  Control of Candida albicans metabolism and biofilm formation by Pseudomonas aeruginosa phenazines.

Authors:  Diana K Morales; Nora Grahl; Chinweike Okegbe; Lars E P Dietrich; Nicholas J Jacobs; Deborah A Hogan
Journal:  MBio       Date:  2013-01-29       Impact factor: 7.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.